The associations between MDM4 gene polymorphisms and cancer risk

Ming-Jie Wang; Yong-Jun Luo; Zhi-Yong Shi; Xiao-Liang Xu; Guo-Liang Yao; Rui-Ping Liu; Hui Zhao

doi:10.18632/oncotarget.10877

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

The associations between MDM4 gene polymorphisms and cancer risk

Ming-Jie Wang, Yong-Jun Luo, Zhi-Yong Shi, Xiao-Liang Xu, Guo-Liang Yao, Rui-Ping Liu _ and Hui Zhao

PDF | HTML | How to cite

Oncotarget. 2016; 7:55611-55623. https://doi.org/10.18632/oncotarget.10877

Metrics: PDF 1350 views | HTML 1978 views | ?

Abstract

Ming-Jie Wang1,*, Yong-Jun Luo2,*, Zhi-Yong Shi3,*, Xiao-Liang Xu4, Guo-Liang Yao5, Rui-Ping Liu1, Hui Zhao6

1Department of Orthopedics, Affiliated Hospital of Nanjing Medical University, Changzhou Second People’s Hospital, Changzhou 213003, China

2Department of Orthopedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

3Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China National Clinical Research Center for Neurological Diseases, Beijing 100050, China

4Department of Liver Surgery of Jiangsu Province People's Hospital, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

5Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

6Department of General Surgery, Third Affiliated Hospital of Nantong University, Wuxi, 214000, China

*These authors contributed equally to this work

Correspondence to:

Rui-Ping Liu, email: [email protected]

Hui Zhao, email: [email protected]

Keywords: MDM4, single nucleotide polymorphisms, meta-analysis, cancer

Received: April 15, 2016 Accepted: July 10, 2016 Published: July 28, 2016

ABSTRACT

Considerable studies have investigated the associations between MDM4 gene polymorphisms and cancer risk recently, but with contradictory results. The aim of this meta-analysis was to evaluate the associations between MDM4 gene polymorphisms and cancer risk. Relevant studies were identified by a systematic search of PubMed, Embase, and CNKI databases. Crude odds ratios (ORs) and 95% confidence intervals (CIs) were used to describe the strength of the associations. Fifty-six studies published in 11 publications involving 18,910 cases and 51,609 controls were included in this meta-analysis. Five MDM4 gene polymorphisms were evaluated: rs4245739, rs1563828, rs11801299, rs10900598, and rs1380576. Our analyses suggested that the rs4245739 polymorphism was significantly associated with overall cancer risk. Furthermore, stratification analyses of ethnicity indicated that rs4245739 decreased the risk of cancer among the Asian population, and stratification analyses of smoking status indicated that rs4245739 decreased the risk of cancer among nonsmokers. However, stratification analyses of cancer type and sex suggested that rs4245739 was not related to cancer risk. There were no associations of rs1563828, rs11801299, rs10900598, or rs1380576 with overall cancer risk. In conclusion, our analyses indicated that rs4245739 polymorphism in the MDM4 gene may play an important role in the etiology of cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 10877

Publication Alerts

Research Papers:

The associations between MDM4 gene polymorphisms and cancer risk

Abstract